These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36529835)

  • 1. Impact of Sotorasib on the Pharmacokinetics and Pharmacodynamics of Metformin, a MATE1/2K Substrate, in Healthy Subjects.
    Vuu I; Wahlstrom J; Houk BE
    Clin Pharmacokinet; 2023 Feb; 62(2):267-275. PubMed ID: 36529835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No Effect of Plazomicin on the Pharmacokinetics of Metformin in Healthy Subjects.
    Choi T; Komirenko AS; Riddle V; Kim A; Dhuria SV
    Clin Pharmacol Drug Dev; 2019 Aug; 8(6):818-826. PubMed ID: 30605260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Omecamtiv Mecarbil on the Pharmacokinetics of Metformin, a Probe Substrate for MATE1/MATE2-K, in Healthy Subjects.
    Trivedi A; Oberoi RK; Jafarinasabian P; Zhang H; Spring M; Flach S; Abbasi S; Dutta S; Lee E
    Clin Drug Investig; 2021 Jul; 41(7):647-652. PubMed ID: 34097256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Drug-Drug Interaction Study to Evaluate the Impact of Rimegepant on OCT2- and MATE1-Mediated Transport of Metformin in Healthy Participants.
    Bhardwaj R; Morris B; Matschke K; Bertz R; Croop R; Liu J
    Clin Pharmacol Drug Dev; 2024 May; 13(5):465-473. PubMed ID: 38174905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative Bioavailability of Sotorasib Following Administration as a Water Dispersion to Healthy Subjects and Compatibility With Enteral Administration.
    Cardona P; Spring M; Bao J; Xie Y; Houk B
    Clin Pharmacol Drug Dev; 2024 Sep; ():. PubMed ID: 39230186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sotorasib: a treatment for non-small cell lung cancer with the KRAS G12C mutation.
    Zheng X; Luo J; Liu W; Ashby CR; Chen ZS; Lin L
    Drugs Today (Barc); 2022 Apr; 58(4):175-185. PubMed ID: 35412531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin.
    Hibma JE; Zur AA; Castro RA; Wittwer MB; Keizer RJ; Yee SW; Goswami S; Stocker SL; Zhang X; Huang Y; Brett CM; Savic RM; Giacomini KM
    Clin Pharmacokinet; 2016 Jun; 55(6):711-21. PubMed ID: 26597253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition.
    Barrios-Bernal P; Lucio-Lozada J; Ramos-Ramírez M; Hernández-Pedro N; Arrieta O
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a High-Fat Meal on the Pharmacokinetics of Sotorasib, a KRAS G12C Inhibitor.
    Cardona P; Dutta S; Houk B
    Clin Pharmacol Drug Dev; 2024 Nov; 13(11):1219-1226. PubMed ID: 39016337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A drug-drug interaction study to evaluate the impact of peficitinib on OCT1- and MATE1-mediated transport of metformin in healthy volunteers.
    Shibata M; Toyoshima J; Kaneko Y; Oda K; Nishimura T
    Eur J Clin Pharmacol; 2020 Aug; 76(8):1135-1141. PubMed ID: 32472157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic Drug-Drug Interaction Studies Between Trilaciclib and Midazolam, Metformin, Rifampin, Itraconazole, and Topotecan in Healthy Volunteers and Patients with Extensive-Stage Small-Cell Lung Cancer.
    Li C; Horton JK; Sale M; Curd L; Goti V; Tao W; Beelen A
    Clin Drug Investig; 2022 Aug; 42(8):679-692. PubMed ID: 35842567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Pharmacokinetics of Metformin Following Coadministration With Doravirine in Healthy Volunteers.
    Sanchez RI; Yee KL; Fan L; Cislak D; Martell M; Jordan HR; Iwamoto M; Khalilieh S
    Clin Pharmacol Drug Dev; 2020 Jan; 9(1):107-114. PubMed ID: 30973682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sotorasib as First-Line Treatment for Advanced KRAS G12C-Mutated Non-Small Cell Lung Carcinoma: A Case Report.
    Iska S; Alley EW
    Case Rep Oncol; 2023; 16(1):177-181. PubMed ID: 37008835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, Distribution, Metabolism, and Excretion of [
    Dahal UP; Rock BM; Rodgers J; Shen X; Wang Z; Wahlstrom JL
    Drug Metab Dispos; 2022 May; 50(5):600-612. PubMed ID: 35153196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a simple high-performance liquid chromatography-ultraviolet method for sotorasib quantification in human plasma: Implications for therapeutic drug monitoring.
    Hikita E; Gando Y; Chubachi H; Shirota M; Kushiyama A; Yasu T
    Drug Discov Ther; 2023 Sep; 17(4):289-293. PubMed ID: 37599084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic interaction between DWP16001, an sodium-glucose cotransporter 2 inhibitor and metformin in healthy subjects.
    Kim B; Huh KY; Hwang JG; Nah J; Huh W; Cho JM; Jang IJ; Yu KS; Kim Y; Lee S
    Br J Clin Pharmacol; 2023 Apr; 89(4):1462-1470. PubMed ID: 36422809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of fedratinib on the pharmacokinetics of transporter probe substrates using a cocktail approach.
    Ogasawara K; Wood-Horrall RN; Thomas M; Thomas M; Liu L; Liu M; Xue Y; Surapaneni S; Carayannopoulos LN; Zhou S; Palmisano M; Krishna G
    Cancer Chemother Pharmacol; 2021 Dec; 88(6):941-952. PubMed ID: 34477937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCL-X
    Khan S; Wiegand J; Zhang P; Hu W; Thummuri D; Budamagunta V; Hua N; Jin L; Allegra CJ; Kopetz SE; Zajac-Kaye M; Kaye FJ; Zheng G; Zhou D
    J Hematol Oncol; 2022 Mar; 15(1):23. PubMed ID: 35260176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCB1 limits brain exposure of the KRAS
    Loos NHC; Retmana IA; Li W; Martins MLF; Lebre MC; Sparidans RW; Beijnen JH; Schinkel AH
    Pharmacol Res; 2022 Apr; 178():106137. PubMed ID: 35192958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA Approval Summary: Sotorasib for KRAS G12C-Mutated Metastatic NSCLC.
    Nakajima EC; Drezner N; Li X; Mishra-Kalyani PS; Liu Y; Zhao H; Bi Y; Liu J; Rahman A; Wearne E; Ojofeitimi I; Hotaki LT; Spillman D; Pazdur R; Beaver JA; Singh H
    Clin Cancer Res; 2022 Apr; 28(8):1482-1486. PubMed ID: 34903582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.